Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Medicated Skin Care in Italy

Published by: Euromonitor International

Published: Mar. 1, 2009 - 64 Pages


Table of Contents


Medicated Skin Care in Italy
Euromonitor International
March 2009
Executive Summary
A Positive Result Driven by Price Liberalisation
the Weak Effects of Deregulation
A Fragmented Market Led by Bayer
Chemists/pharmacies Remain the Undisputed Leaders
Vitamins and Dietary Supplements Will Be Growth Driver
Key Trends and Developments
A Very Old Country
What Price? the Effects of Price Liberalisation
the Results of the New Bersani Law
Are Parapharmacies/drugstores True Competitors?
the Need for A Healthier Lifestyle
Pharmaclick - A New Distributor?
Market Data
Table 1 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 2 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 3 OTC Healthcare Company Shares by Value 2004-2008
Table 4 OTC Healthcare Brand Shares by Value 2005-2008
Table 5 Penetration of Private Label by Sector 2003-2008
Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging and Waste
Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventive Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
Definitions
Sources
Summary 2 Research Sources
A Menarini Industrie Farmaceutiche Riunite SRL
Strategic Direction
Key Facts
Summary 3 A Menarini Industrie Farmaceutiche Riunite Srl: Key Facts
Summary 4 A Menarini Industrie Farmaceutiche Riunite Srl: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2008
Aziende Chimiche Riunite Angelini Francesco Acraf SpA
Strategic Direction
Key Facts
Summary 6 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Key Facts
Summary 7 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Operational Indicators
Company Background
Production
Summary 8 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics 2007
Competitive Positioning
Summary 9 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2008
Bayer SpA
Strategic Direction
Key Facts
Summary 10 Bayer SpA: Key Facts
Summary 11 Bayer SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Bayer SpA: Competitive Position 2008
Bracco SpA
Strategic Direction
Key Facts
Summary 13 Bracco SpA: Key Facts
Summary 14 Bracco SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 15 Bracco SpA: Competitive Position 2008
Chiesi Farmaceutici SpA
Strategic Direction
Key Facts
Summary 16 Chiesi Farmaceutici SpA: Key Facts
Summary 17 Chiesi Farmaceutici SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 18 Chiesi Farmaceutici SpA: Competitive Position 2008
Perfetti Van Melle SpA
Strategic Direction
Key Facts
Summary 19 Perfetti Van Melle SpA: Key Facts
Summary 20 Perfetti Van Melle SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 21 Perfetti Van Melle SpA: Competitive Position 2008
Recordati Industria Chimica E Farmaceutica SpA
Strategic Direction
Key Facts
Summary 22 Recordati Industria Chimica e Farmaceutica SpA: Key Facts
Summary 23 Recordati Industria Chimica e Farmaceutica SpA: Operational Indicators
Company Background
Production
Summary 24 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics 2007
Competitive Positioning
Summary 25 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2008
Sanofi-aventis SpA
Strategic Direction
Key Facts
Summary 26 Sanofi-Aventis SpA: Key Facts
Summary 27 Sanofi-Aventis SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 28 Sanofi-Aventis SpA: Competitive Position 2008
Sigma-tau Industrie Farmaceutiche Riunite SpA
Strategic Direction
Key Facts
Summary 29 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Key Facts
Summary 30 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 31 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Competitive Position 2008
Zambon Italia SpA
Strategic Direction
Key Facts
Summary 32 Zambon Italia SpA: Key Facts
Summary 33 Zambon Italia SpA: Operational Indicators
Company Background
Production
Summary 34 Zambon Italia SpA: Production Statistics 2007
Competitive Positioning
Summary 35 Zambon Italia SpA: Competitive Position 2008
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 10 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 11 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 12 Herbal vs Standard Medicated Skin Care 2003-2008
Table 13 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 14 Medicated Skin Care Company Shares by Value 2004-2008
Table 15 Medicated Skin Care Brand Shares by Value 2005-2008
Table 16 Acne Treatments Brand Shares by Value 2005-2008
Table 17 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 19 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013

Abstract

Euromonitor International's Medicated Skin Care in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
  • Get a detailed picture of the medicated skin care industry
  • Identify factors driving change
  • Understand the competitive environment, the market’s major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009